报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 2.25% | -38.52% | 116.35% | 85/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 1.04% | -29.25% | 131.11% | 84/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 0.45% | -67.15% | -83.27% | 90/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 2.69% | 0.75% | -26.5% | 85/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 3.66% | 15.09% | 148.98% | 77/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 1.47% | -8.13% | 7.3% | 92/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 1.37% | 7.03% | -48.69% | 75/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 2.67% | -89.95% | -16.04% | 102/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 3.18% | -91.5% | 98.75% | 97/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 1.6% | -93.32% | 25% | 98/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 1.28% | 2% | -95.18% | 79/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 26.58% | 27.79% | -28.97% | 24/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 37.42% | 2% | 56.31% | 9/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 23.94% | 139.4% | 15.1% | 9/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2020-12-31 | 20.8% | -26.86% | 108% | 45/129 | 25.82% | 热景生物 | 57.63% | 行业排名> |
2020-06-30 | 10% | 2% | -64.84% | 42/129 | 15.16% | 中红医疗 | 168% | 行业排名> |
2019-12-31 | 28.44% | -8.82% | -8.82% | 17/129 | 14.38% | 圣湘生物 | 112.46% | 行业排名> |
2018-12-31 | 31.19% | 6.56% | 6.56% | 15/129 | 12.98% | 博拓生物 | 108.13% | 行业排名> |
2017-12-31 | 29.27% | 2% | 2% | 16/129 | 13.82% | 圣湘生物 | 29.33% | 行业排名> |